Journal of the Korean Ophthalmological Society 2004;45(5):720-724.
Published online May 1, 2004.
Increased Tear TNF-alpha and MMP-9 in Patients with Necrotizing Scleritis after Pterygium Excision.
Jung Chul Shin, Chan Young Im, Joon H Lee, Kyoung Yul Seo
Institute of Vision Research, Department of Ophthalmology, Yonsei University college of Medicine, #134 Shinchon-dong Seodeammon-gu, Seoul, Korea. seoky@yumc.yonsei.ac.kr
익상편 절제술 후 괴사성 공막염이 발생한 환자의 눈물에서 TNF-alpha 와 MMP-9 의 증가
신정철 ( Sin Jeong Cheol ) , 임찬영 ( Im Chan Yeong ) , 이준행 ( Lee Jun Haeng ) , 서경률 ( Seo Gyeong Lyul )
Abstract
PURPOSE
We collected tear or scleral tissues of necrotizing scleritis after pterygium excision, and evaluated them for tumor necrosis factor (TNF)-alpha and matrix metalloproteinase (MMP)-9 to elucidate the molecular basis and seek for treatment of this disease. METHODS: Three patients with necrotizing scleritis after pterygium excision were evaluated for MMP-9 and TNF-alpha in tear and scleral tissue by Western blot analysis. RESULTS: Before treatment with corticosteroid, the patients' tear samples showed increased expression of TNF-alpha and MMP-9 compared to those of the contralateral eye. After treatment, the expression of TNF-alpha and MMP-9 was decreased compared to those of the pre-treated tear samples. The patients' sclera showed increased expression of MMP-9 compared to that of the donors' sclera and the patients' conjunctiva. CONCLUSIONS: Our results suggest that cytokine-related inflammation plays a role in the pathophysiology of necrotizing scleritis and strongly supports, under the guarantee of negative microbiological culture, the prompt use of corticosteroid and immunosuppressive agents to help suppress the progression of this disease.
Key Words: Corticosteroid;Matrix metalloproteinase-9;Necrotizing scleritis;Tumor necrosis factor-alpha


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next